[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cerus Corp (CERS)

Cerus Corp (CERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 502,926
  • Shares Outstanding, K 200,369
  • Annual Sales, $ 233,800 K
  • Annual Income, $ -15,630 K
  • EBIT $ -3 M
  • EBITDA $ -2 M
  • 60-Month Beta 1.62
  • Price/Sales 2.53
  • Price/Cash Flow N/A
  • Price/Book 7.63

Options Overview Details

View History
  • Implied Volatility 130.50% (+1.49%)
  • Historical Volatility 94.42%
  • IV Percentile 35%
  • IV Rank 15.98%
  • IV High 582.69% on 03/03/26
  • IV Low 44.51% on 06/06/25
  • Expected Move (DTE 34) 0.61 (25.08%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 22
  • Volume Avg (30-Day) 438
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 6,939
  • Open Int (30-Day) 6,067
  • Expected Range 1.83 to 3.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-0.03
  • Growth Rate Est. (year over year) +3,330,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.85 +30.27%
on 04/23/26
3.15 -23.49%
on 05/01/26
+0.39 (+19.31%)
since 04/15/26
3-Month
1.62 +48.77%
on 03/12/26
3.15 -23.49%
on 05/01/26
+0.17 (+7.59%)
since 02/13/26
52-Week
1.15 +109.57%
on 08/21/25
3.15 -23.49%
on 05/01/26
+1.12 (+86.82%)
since 05/15/25

Most Recent Stories

More News
Cerus: Q1 Earnings Snapshot

Cerus: Q1 Earnings Snapshot

CERS : 2.42 (-3.59%)
Cerus Corporation Announces First Quarter 2026 Financial Results

First Quarter 2026 Total Revenue of $59.9 million, Up 23% Over Prior Year; First Quarter 2026 Product Revenue of $53.7 million, Up 24% Over Prior Year Raising Full Year...

CERS : 2.42 (-3.59%)
Cerus Spent a Year Building Momentum but Tomorrow's Call Decides if Anyone Noticed

Barchart Research What to Expect from CERS Earnings CERS Generated April 29, 2026 Current Price $1.9200 EPS Estimate $$-0.03 Consensus Rating Moderate Buy Average Move 8.18% Cerus Spent a Year Building...

CERS : 2.42 (-3.59%)
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood System....

CERS : 2.42 (-3.59%)
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a...

CERS : 2.42 (-3.59%)
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

William “Obi” Greenman to become Executive Chairman Leadership changes to take effect July 1, 2026

CERS : 2.42 (-3.59%)
Cathie Wood Bets $19 Million on 5 Beaten-Down Stocks

Cathie Woods’s ARK Invest deploys $19 million across five growth stocks in this uncertain market.

DKNG : 25.50 (+1.39%)
ARKF : 41.01 (-2.33%)
CMPS : 10.36 (-2.45%)
ARKW : 144.42 (-2.19%)
ARKG : 28.56 (-2.12%)
CNTN : 3.59 (-4.27%)
CERS : 2.42 (-3.59%)
HOOD : 77.61 (-3.83%)
ARKK : 75.73 (-2.91%)
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 2.42 (-3.59%)
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

2025 Total Revenue of $233.8 million, up 16% from 2024; 2025 Product Revenue of $206.1 million, up 14% from 2024 Strengthened Financial Foundation Through Strong Commercial...

CERS : 2.42 (-3.59%)
Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

Cerus Corporation (Nasdaq: CERS) announced today that members of the Company’s management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at 10:30...

CERS : 2.42 (-3.59%)

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 2.87
2nd Resistance Point 2.79
1st Resistance Point 2.65
Last Price 2.42
1st Support Level 2.43
2nd Support Level 2.36
3rd Support Level 2.22

See More

52-Week High 3.15
Last Price 2.42
Fibonacci 61.8% 2.39
Fibonacci 50% 2.15
Fibonacci 38.2% 1.91
52-Week Low 1.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.